#HSBC on #SunPharma
Buy, TP Rs 1790
US FDA issued (OAI) status for Co’s Dadra plant; this adds on regulatory overhang
Expect its US generic sales (excl. gRevlimid) to remain range-bound on FDA issues & low visibility on launches
Specialty sales remain key for earnings growth
